Filing Details
- Accession Number:
- 0001610717-24-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-04 18:05:51
- Reporting Period:
- 2024-01-02
- Accepted Time:
- 2024-01-04 18:05:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1880438 | An2 Therapeutics Inc. | ANTX | Pharmaceutical Preparations (2834) | 820606654 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1914503 | Eric Easom | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-02 | 2,777 | $20.09 | 2,130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,015,766 | Indirect | See Footnote |
| Common Stock | 97,058 | Indirect | See Footnote |
| Common Stock | 97,058 | Indirect | See Footnote |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 29, 2023.
- Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
- Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
- Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.
Billionaire Hedge Funds
